Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed
September 20, 2024 08:43 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1 (CB1) inverse...
At 13.1% CAGR, Rare Diseases Market Size Anticipated to Reach USD 547.5 Billion by 2030: Prophecy Market Insights
August 30, 2024 09:13 ET
|
PMI
Covina, Aug. 30, 2024 (GLOBE NEWSWIRE) -- According to Prophecy Market Insights, the global rare disease market size and share value is projected to grow from USD 161.4 Billion in 2020 and is...
Kymera Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy
July 08, 2024 16:05 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using...
Asia-Pacific Wearable Patches Market Research Report 2024: A $5.3 Billion Market by 2031, Fueled by Healthcare, Fitness Tracking, and Remote Patient Monitoring
April 30, 2024 10:43 ET
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Wearable Patches Market: Focus on Usage Type, Application, End User, and Country - Analysis and Forecast, 2023-2031" report has been...
Europe Cell and Gene Therapy Manufacturing QC Market Research Report 2024
February 28, 2024 09:29 ET
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Europe Cell and Gene Therapy Manufacturing QC Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The...
Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Analysis and Forecast, 2023-2033: Rising Number of Approved Therapies and Increasing Need for Expanded Infrastructure
February 27, 2024 06:46 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Cell and Gene Therapy Manufacturing QC Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's...
Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer
December 04, 2023 08:00 ET
|
Zenas BioPharma
WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and...
Pharvaris to Present at the GA²LEN UCARE Conference 2023
November 30, 2023 06:50 ET
|
Pharvaris N.V.
ZUG, Switzerland, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary...
Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism
September 28, 2023 11:15 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Huawei's Business Operations and Development Strategies Following the United States Ban, 2023 Report
April 26, 2023 07:13 ET
|
Research and Markets
Dublin, April 26, 2023 (GLOBE NEWSWIRE) -- The "Huawei's Business Operations and Development Strategies Following the U.S. Ban " company profile has been added to ResearchAndMarkets.com's...